Search - tctmd.com

Displaying 121 - 140 of 783

Sort: Relevancy | Date

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Daily News

Defying Earlier GLP-1 Data, Study in Teens Sees Possible Mental Health Gains

L.A. McKeown

October 22, 2024

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Daily News

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

L.A. McKeown

October 01, 2024

News Daily News

Deprescribing Antihypertensives May Slow Cognitive Decline in Nursing Home Patients

L.A. McKeown

September 27, 2024

News Features

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special

L.A. McKeown

September 25, 2024

News Daily News

Pandemic Burnout Survey Uncovers Work-Life Stressors Among Cardiology Staff

L.A. McKeown

September 19, 2024

News Conference News ESC 2024

More Data Diminish Support for Cath Lab Fasting Rules: SCOFF

L.A. McKeown

September 10, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Conference News ESC 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

L.A. McKeown

August 31, 2024

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

L.A. McKeown

August 23, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs

L.A. McKeown

August 15, 2024

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Daily News

ACC Offers Guidance for Remote Patient Monitoring

L.A. McKeown

August 06, 2024

News Daily News

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

L.A. McKeown

August 05, 2024

Advertisement

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

Defying Earlier GLP-1 Data, Study in Teens Sees Possible Mental Health Gains

AHA Statement Outlines Cardiac Contributions to Brain Health

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

Deprescribing Antihypertensives May Slow Cognitive Decline in Nursing Home Patients

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special

Pandemic Burnout Survey Uncovers Work-Life Stressors Among Cardiology Staff

More Data Diminish Support for Cath Lab Fasting Rules: SCOFF

September 2024 Dispatch for the CV Team

Polypills Show Promise in Diverse Hypertensive Patient Groups

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

Scientific Statement Reviews Current Antithrombotic Options in PAD

Platelet Hyperreactivity Score May Improve CVD Risk Detection

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

ACC Offers Guidance for Remote Patient Monitoring

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content